Amavita Paracetamol 500
Amavita Paracetamol 500 is a medicine authorised by Swissmedic under authorisation number 61221. The authorisation holder is Amavita Health Care AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 21 December 2009 and the authorisation is valid without a time limit. ATC code N02BE01 places the medicine in the group Analgesics.
| Authorisation number | 61221 |
|---|---|
| Name | Amavita Paracetamol 500 |
| Full name | Amavita Paracetamol 500, Tabletten |
| Authorisation holder | Amavita Health Care AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | N02BE01 |
| First authorisation | 21 December 2009 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Amavita Paracetamol 500, Tabletten | D | 21 December 2009 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 20 | Tablette(n) | N02BE01 | 01.01.1. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Amavita Paracetamol 500 authorised in Switzerland?
Yes. Amavita Paracetamol 500 is authorised by Swissmedic under authorisation number 61221, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Amavita Paracetamol 500 have?
Amavita Paracetamol 500 is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Amavita Paracetamol 500?
The authorisation holder is Amavita Health Care AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.